AGE 0 3 0 3 B-age
: 3 4 3 4 O
≤ 5 6 5 6 O
30 7 9 7 9 B-upper_bound
years 10 15 10 15 I-upper_bound
of 16 18 16 18 O
age 19 22 19 22 B-age

Age 0 3 23 26 B-age
- 3 4 26 27 O
adjusted 4 12 27 35 O
normal 13 19 36 42 O
serum 20 25 43 48 B-clinical_variable
creatinine 26 36 49 59 I-clinical_variable

At 0 2 60 62 O
least 3 8 63 68 O
2 9 10 69 70 B-lower_bound
months 11 17 71 77 I-lower_bound
post 18 22 78 82 O
- 22 23 82 83 O
autologous 23 33 83 93 O
stem 34 38 94 98 B-treatment
cell 39 43 99 103 I-treatment
transplant 44 54 104 114 I-treatment
or 55 57 115 117 O
at 58 60 118 120 O
least 61 66 121 126 O
3 67 68 127 128 B-lower_bound
months 69 75 129 135 I-lower_bound
post 76 80 136 140 O
- 80 81 140 141 O
allogeneic 81 91 141 151 B-treatment
transplant 92 102 152 162 I-treatment

Biologic 0 8 163 171 B-treatment
( 9 10 172 173 I-treatment
anti 10 14 173 177 I-treatment
- 14 15 177 178 I-treatment
cancer 15 21 178 184 I-treatment
agent 22 27 185 190 I-treatment
) 27 28 190 191 I-treatment

Clinically 0 10 192 202 O
significant 11 22 203 214 O
unrelated 23 32 215 224 O
systemic 33 41 225 233 B-chronic_disease
illness 42 49 234 241 I-chronic_disease

Curative 0 8 242 250 O
therapy 9 16 251 258 B-treatment
may 17 20 259 262 O
include 21 28 263 270 O
surgery 29 36 271 278 B-treatment
, 36 37 278 279 O
radiation 38 47 280 289 B-treatment
therapy 48 55 290 297 I-treatment
, 55 56 297 298 O
chemotherapy 57 69 299 311 B-treatment
, 69 70 311 312 O
or 71 73 313 315 O
any 74 77 316 319 O
combination 78 89 320 331 O
of 90 92 332 334 O
these 93 98 335 340 O
modalities 99 109 341 351 O

Defined 0 7 352 359 O
as 8 10 360 362 O
no 11 13 363 365 O
dyspnea 14 21 366 373 B-chronic_disease
at 22 24 374 376 O
rest 25 29 377 381 O

Histologically 0 14 382 396 O
confirmed 15 24 397 406 O
malignant 25 34 407 416 O
solid 35 40 417 422 B-cancer
tumors 41 47 423 429 I-cancer
, 47 48 429 430 O
which 49 54 431 436 O
may 55 58 437 440 O
include 59 66 441 448 O
but 67 70 449 452 O
are 71 74 453 456 O
not 75 78 457 460 O
limited 79 86 461 468 O
to 87 89 469 471 O
rhabdomyosarcoma 90 106 472 488 B-cancer
and 107 110 489 492 O
other 111 116 493 498 O
soft 117 121 499 503 B-cancer
tissue 122 128 504 510 I-cancer
sarcomas 129 137 511 519 I-cancer
, 137 138 519 520 O
Ewing 139 144 521 526 B-cancer
's 144 146 526 528 I-cancer
sarcoma 147 154 529 536 I-cancer
family 155 161 537 543 O
of 162 164 544 546 O
tumors 165 171 547 553 O
, 171 172 553 554 O
osteosarcoma 173 185 555 567 B-cancer
, 185 186 567 568 O
neuroblastoma 187 200 569 582 B-cancer
, 200 201 582 583 O
Wilms 202 207 584 589 B-cancer
' 207 208 589 590 I-cancer
tumor 209 214 591 596 I-cancer
, 214 215 596 597 O
hepatic 216 223 598 605 B-cancer
tumors 224 230 606 612 I-cancer
, 230 231 612 613 O
germ 232 236 614 618 B-cancer
cell 237 241 619 623 I-cancer
tumors 242 248 624 630 I-cancer
, 248 249 630 631 O
and 250 253 632 635 O
desmoid 254 261 636 643 B-cancer
tumors 262 268 644 650 I-cancer

Immunotherapy 0 13 651 664 B-treatment

Implant 0 7 665 672 B-treatment
or 8 10 673 675 O
prosthesis 11 21 676 686 B-treatment
or 22 24 687 689 O
scar 25 29 690 694 O
tissue 30 36 695 701 O
within 37 43 702 708 O
the 44 47 709 712 O
path 48 52 713 717 O
of 53 55 718 720 O
the 56 59 721 724 O
HIFU 60 64 725 729 B-treatment
beam 65 69 730 734 I-treatment

Inability 0 9 735 744 O
to 10 12 745 747 O
tolerate 13 21 748 756 O
stationary 22 32 757 767 O
position 33 41 768 776 O
during 42 48 777 783 O
HIFU 49 53 784 788 B-treatment

Inability 0 9 789 798 O
to 10 12 799 801 O
undergo 13 20 802 809 O
MRI 21 24 810 813 B-treatment
and/or 25 31 814 820 O
contraindication 32 48 821 837 O
for 49 52 838 841 O
MRI 53 56 842 845 O

Lesion 0 6 846 852 B-cancer
in 7 9 853 855 I-cancer
the 10 13 856 859 I-cancer
skull 14 19 860 865 I-cancer

Myelosuppressive 0 16 866 882 B-treatment
chemotherapy 17 29 883 895 I-treatment

No 0 2 896 898 O
limitation 3 13 899 909 O
on 14 16 910 912 O
the 17 20 913 916 O
number 21 27 917 923 O
of 28 30 924 926 O
prior 31 36 927 932 B-treatment
chemotherapy 37 49 933 945 I-treatment
regimens 50 58 946 954 I-treatment
that 59 63 955 959 O
the 64 67 960 963 O
patient 68 75 964 971 O
may 76 79 972 975 O
have 80 84 976 980 O
received 85 93 981 989 O
prior 94 99 990 995 O
to 100 102 996 998 O
study 103 108 999 1004 O
entry 109 114 1005 1010 O

No 0 2 1011 1013 O
other 3 8 1014 1019 O
anti 9 13 1020 1024 B-treatment
- 13 14 1024 1025 I-treatment
cancer 14 20 1025 1031 I-treatment
therapy 21 28 1032 1039 I-treatment
( 29 30 1040 1041 O
chemotherapy 30 42 1041 1053 B-treatment
, 42 43 1053 1054 O
biological 44 54 1055 1065 B-treatment
therapy 55 62 1066 1073 I-treatment
, 62 63 1073 1074 O
radiation 64 73 1075 1084 B-treatment
therapy 74 81 1085 1092 I-treatment
) 81 82 1092 1093 O
is 83 85 1094 1096 O
permitted 86 95 1097 1106 O
during 96 102 1107 1113 O
HIFU 103 107 1114 1118 B-treatment
treatment 108 117 1119 1128 I-treatment
and 118 121 1129 1132 O
post 122 126 1133 1137 O
treatment 127 136 1138 1147 O
follow 137 143 1148 1154 O
up 144 146 1155 1157 O
for 147 150 1158 1161 O
tolerability 151 163 1162 1174 O

Normal 0 6 1175 1181 B-clinical_variable
PT 7 9 1182 1184 I-clinical_variable
, 9 10 1184 1185 O
PTT 11 14 1186 1189 B-clinical_variable
and 15 18 1190 1193 O
INR 19 22 1194 1197 B-clinical_variable
< 23 24 1198 1199 O
1.5 25 28 1200 1203 B-upper_bound
x 29 30 1204 1205 I-upper_bound
ULN 31 34 1206 1209 I-upper_bound

Patients 0 8 1210 1218 O
> 9 10 1219 1220 O
10 11 13 1221 1223 B-lower_bound
years 14 19 1224 1229 I-lower_bound
old 20 23 1230 1233 O

Patients 0 8 1234 1242 O
currently 9 18 1243 1252 O
receiving 19 28 1253 1262 O
other 29 34 1263 1268 O
anticancer 35 45 1269 1279 B-treatment
agents 46 52 1280 1286 I-treatment

Patients 0 8 1287 1295 O
currently 9 18 1296 1305 O
receiving 19 28 1306 1315 O
other 29 34 1316 1321 O
investigational 35 50 1322 1337 B-treatment
agents 51 57 1338 1344 I-treatment

Patients 0 8 1345 1353 O
must 9 13 1354 1358 O
have 14 18 1359 1363 O
fully 19 24 1364 1369 O
recovered 25 34 1370 1379 O
from 35 39 1380 1384 O
the 40 43 1385 1388 O
acute 44 49 1389 1394 O
toxic 50 55 1395 1400 O
effects 56 63 1401 1408 O
of 64 66 1409 1411 O
all 67 70 1412 1415 O
prior 71 76 1416 1421 B-treatment
chemotherapy 77 89 1422 1434 I-treatment
, 89 90 1434 1435 O
immunotherapy 91 104 1436 1449 B-treatment
, 104 105 1449 1450 O
or 106 108 1451 1453 O
radiotherapy 109 121 1454 1466 B-treatment
prior 122 127 1467 1472 O
to 128 130 1473 1475 O
entering 131 139 1476 1484 O
on 140 142 1485 1487 O
this 143 147 1488 1492 O
study 148 153 1493 1498 O

Patients 0 8 1499 1507 O
who 9 12 1508 1511 O
are 13 16 1512 1515 O
unable 17 23 1516 1522 O
to 24 26 1523 1525 O
walk 27 31 1526 1530 O
because 32 39 1531 1538 O
of 40 42 1539 1541 O
paralysis 43 52 1542 1551 B-chronic_disease
or 53 55 1552 1554 O
motor 56 61 1555 1560 O
weakness 62 70 1561 1569 O
, 70 71 1569 1570 O
but 72 75 1571 1574 O
who 76 79 1575 1578 O
are 80 83 1579 1582 O
up 84 86 1583 1585 O
in 87 89 1586 1588 O
a 90 91 1589 1590 O
wheelchair 92 102 1591 1601 O
will 103 107 1602 1606 O
be 108 110 1607 1609 O
considered 111 121 1610 1620 O
ambulatory 122 132 1621 1631 O
for 133 136 1632 1635 O
the 137 140 1636 1639 O
purpose 141 148 1640 1647 O
of 149 151 1648 1650 O
calculating 152 163 1651 1662 O
the 164 167 1663 1666 O
performance 168 179 1667 1678 O
score 180 185 1679 1684 O

Peripheral 0 10 1685 1695 O
absolute 11 19 1696 1704 B-clinical_variable
neutrophil 20 30 1705 1715 I-clinical_variable
count 31 36 1716 1721 I-clinical_variable
( 37 38 1722 1723 I-clinical_variable
ANC 38 41 1723 1726 I-clinical_variable
) 41 42 1726 1727 I-clinical_variable
of 43 45 1728 1730 O
≥750/µL 46 53 1731 1738 O

Platelet 0 8 1739 1747 B-clinical_variable
count 9 14 1748 1753 I-clinical_variable
≥75,000/µL 15 25 1754 1764 O

Radiation 0 9 1765 1774 B-treatment
therapy 10 17 1775 1782 I-treatment

Radiographically 0 16 1783 1799 O
evaluable 17 26 1800 1809 O
or 27 29 1810 1812 O
measurable 30 40 1813 1823 O
solid 41 46 1824 1829 B-cancer
tumor 47 52 1830 1835 I-cancer
target 53 59 1836 1842 O
lesion(s 60 68 1843 1851 O
) 68 69 1851 1852 O

Stem 0 4 1853 1857 B-treatment
Cell 5 9 1858 1862 I-treatment
Transplantation 10 25 1863 1878 I-treatment

Target 0 6 1879 1885 O
< 7 8 1886 1887 O
1 8 9 1887 1888 B-upper_bound
cm 10 12 1889 1891 I-upper_bound
from 13 17 1892 1896 O
nerve 18 23 1897 1902 B-clinical_variable
plexus 24 30 1903 1909 I-clinical_variable

Target 0 6 1910 1916 B-cancer
lesions 7 14 1917 1924 I-cancer
that 15 19 1925 1929 O
are 20 23 1930 1933 O
pulmonary 24 33 1934 1943 B-cancer
primary 34 41 1944 1951 I-cancer
tumors 42 48 1952 1958 I-cancer
or 49 51 1959 1961 O
metastases 52 62 1962 1972 B-cancer

The 0 3 1973 1976 O
last 4 8 1977 1981 O
dose 9 13 1982 1986 O
of 14 16 1987 1989 O
all 17 20 1990 1993 O
biologic 21 29 1994 2002 B-treatment
agents 30 36 2003 2009 I-treatment
for 37 40 2010 2013 O
the 41 44 2014 2017 O
treatment 45 54 2018 2027 B-treatment
of 55 57 2028 2030 O
the 58 61 2031 2034 O
patient 62 69 2035 2042 O
's 69 71 2042 2044 O
cancer 72 78 2045 2051 B-cancer
( 79 80 2052 2053 O
such 80 84 2053 2057 O
as 85 87 2058 2060 O
retinoids 88 97 2061 2070 B-cancer
or 98 100 2071 2073 O
tyrosine 101 109 2074 2082 B-treatment
kinase 110 116 2083 2089 I-treatment
inhibitors 117 127 2090 2100 I-treatment
) 127 128 2100 2101 O

The 0 3 2102 2105 O
last 4 8 2106 2110 O
dose 9 13 2111 2115 O
of 14 16 2116 2118 O
all 17 20 2119 2122 O
myelosuppressive 21 37 2123 2139 B-treatment
anticancer 38 48 2140 2150 I-treatment
drugs 49 54 2151 2156 I-treatment

The 0 3 2157 2160 O
last 4 8 2161 2165 O
dose 9 13 2166 2170 O
of 14 16 2171 2173 O
all 17 20 2174 2177 O
other 21 26 2178 2183 O
local 27 32 2184 2189 B-treatment
palliative 33 43 2190 2200 I-treatment
( 44 45 2201 2202 I-treatment
limited 45 52 2202 2209 I-treatment
port 53 57 2210 2214 I-treatment
) 57 58 2214 2215 I-treatment
radiation 59 68 2216 2225 I-treatment

The 0 3 2226 2229 O
last 4 8 2230 2234 O
dose 9 13 2235 2239 O
of 14 16 2240 2242 O
colony 17 23 2243 2249 B-treatment
stimulating 24 35 2250 2261 I-treatment
factors 36 43 2262 2269 I-treatment

The 0 3 2270 2273 O
last 4 8 2274 2278 O
dose 9 13 2279 2283 O
of 14 16 2284 2286 O
immunotherapy 17 30 2287 2300 B-treatment
( 31 32 2301 2302 O
monoclonal 32 42 2302 2312 B-treatment
antibody 43 51 2313 2321 I-treatment
or 52 54 2322 2324 O
vaccine 55 62 2325 2332 B-treatment
) 62 63 2332 2333 O

The 0 3 2334 2337 O
last 4 8 2338 2342 O
dose 9 13 2343 2347 O
of 14 16 2348 2350 O
radiation 17 26 2351 2360 B-treatment
to 27 29 2361 2363 O
more 30 34 2364 2368 O
than 35 39 2369 2373 O
25 40 42 2374 2376 B-lower_bound
% 43 44 2377 2378 I-lower_bound
of 45 47 2379 2381 O
marrow 48 54 2382 2388 O
containing 55 65 2389 2399 O
bones 66 71 2400 2405 O
( 72 73 2406 2407 O
pelvis 73 79 2407 2413 O
, 79 80 2413 2414 O
spine 81 86 2415 2420 O
, 86 87 2420 2421 O
skull 88 93 2422 2427 O
) 93 94 2427 2428 O

The 0 3 2429 2432 O
patient 4 11 2433 2440 O
's 11 13 2440 2442 O
cancer 14 20 2443 2449 B-cancer
must 21 25 2450 2454 O
have 26 30 2455 2459 O
relapsed 31 39 2460 2468 O
after 40 45 2469 2474 O
or 46 48 2475 2477 O
failed 49 55 2478 2484 O
to 56 58 2485 2487 O
respond 59 66 2488 2495 O
to 67 69 2496 2498 O
frontline 70 79 2499 2508 O
curative 80 88 2509 2517 O
therapy 89 96 2518 2525 B-treatment
and 97 100 2526 2529 O
there 101 106 2530 2535 O
must 107 111 2536 2540 O
not 112 115 2541 2544 O
be 116 118 2545 2547 O
other 119 124 2548 2553 O
potentially 125 136 2554 2565 O
curative 137 145 2566 2574 O
treatment 146 155 2575 2584 B-treatment
options 156 163 2585 2592 O
available 164 173 2593 2602 O

a 0 1 2603 2604 O
creatinine 2 12 2605 2615 B-clinical_variable
clearance 13 22 2616 2625 I-clinical_variable
≥60 23 26 2626 2629 O
mL 27 29 2630 2632 I-lower_bound
/ 29 30 2632 2633 I-lower_bound
min/1.73 30 38 2633 2641 I-lower_bound
m2 39 41 2642 2644 I-lower_bound

children 0 8 2645 2653 O
≤ 9 10 2654 2655 O
10 11 13 2656 2658 B-upper_bound
years 14 19 2659 2664 I-upper_bound
old 20 23 2665 2668 O

filgrastim 0 10 2669 2679 B-treatment
, 10 11 2679 2680 O
sargramostim 12 24 2681 2693 B-treatment
, 24 25 2693 2694 O
and 26 29 2695 2698 O
erythropoietin 30 44 2699 2713 B-treatment

may 0 3 2714 2717 O
receive 4 11 2718 2725 O
transfusions 12 24 2726 2738 B-treatment

must 0 4 2739 2743 O
be 5 7 2744 2746 O
at 8 10 2747 2749 O
least 11 16 2750 2755 O
1 17 18 2756 2757 B-lower_bound
week 19 23 2758 2762 I-lower_bound
prior 24 29 2763 2768 I-lower_bound
to 30 32 2769 2771 O
study 33 38 2772 2777 O
entry 39 44 2778 2783 O

must 0 4 2784 2788 O
be 5 7 2789 2791 O
at 8 10 2792 2794 O
least 11 16 2795 2800 O
2 17 18 2801 2802 B-lower_bound
weeks 19 24 2803 2808 I-lower_bound
prior 25 30 2809 2814 I-lower_bound
to 31 33 2815 2817 O
study 34 39 2818 2823 O
entry 40 45 2824 2829 O

must 0 4 2830 2834 O
be 5 7 2835 2837 O
at 8 10 2838 2840 O
least 11 16 2841 2846 O
3 17 18 2847 2848 B-lower_bound
weeks 19 24 2849 2854 I-lower_bound
prior 25 30 2855 2860 I-lower_bound
to 31 33 2861 2863 O
study 34 39 2864 2869 O
entry 40 45 2870 2875 O

must 0 4 2876 2880 O
be 5 7 2881 2883 O
at 8 10 2884 2886 O
least 11 16 2887 2892 O
4 17 18 2893 2894 B-lower_bound
weeks 19 24 2895 2900 I-lower_bound
prior 25 30 2901 2906 I-lower_bound
to 31 33 2907 2909 O
study 34 39 2910 2915 O
entry 40 45 2916 2921 O

must 0 4 2922 2926 O
have 5 9 2927 2931 O
a 10 11 2932 2933 O
Karnofsky 12 21 2934 2943 B-clinical_variable
performance 22 33 2944 2955 I-clinical_variable
level 34 39 2956 2961 I-clinical_variable
≥ 40 41 2962 2963 O
50 42 44 2964 2966 B-lower_bound
% 44 45 2966 2967 I-lower_bound

must 0 4 2968 2972 O
have 5 9 2973 2977 O
a 10 11 2978 2979 O
Lansky 12 18 2980 2986 B-clinical_variable
performance 19 30 2987 2998 I-clinical_variable
level 31 36 2999 3004 I-clinical_variable
≥ 37 38 3005 3006 O
50 39 41 3007 3009 B-lower_bound
% 41 42 3009 3010 I-lower_bound

pegfilgrastim 0 13 3011 3024 B-treatment

serious 0 7 3025 3032 B-chronic_disease
infections 8 18 3033 3043 I-chronic_disease
, 18 19 3043 3044 O
hepatic 20 27 3045 3052 B-chronic_disease
, 27 28 3052 3053 O
renal 29 34 3054 3059 B-chronic_disease
or 35 37 3060 3062 O
other 38 43 3063 3068 O
organ 44 49 3069 3074 B-chronic_disease
dysfunction 50 61 3075 3086 I-chronic_disease
, 61 62 3086 3087 O
which 63 68 3088 3093 O
in 69 71 3094 3096 O
the 72 75 3097 3100 O
judgment 76 84 3101 3109 O
of 85 87 3110 3112 O
the 88 91 3113 3116 O
Principal 92 101 3117 3126 O
or 102 104 3127 3129 O
Associate 105 114 3130 3139 O
Investigator 115 127 3140 3152 O
would 128 133 3153 3158 O
compromise 134 144 3159 3169 O
the 145 148 3170 3173 O
patient 149 156 3174 3181 O
's 156 158 3181 3183 O
ability 159 166 3184 3191 O
to 167 169 3192 3194 O
tolerate 170 178 3195 3203 O
the 179 182 3204 3207 O
general 183 190 3208 3215 O
anesthetic 191 201 3216 3226 O
required 202 210 3227 3235 O
for 211 214 3236 3239 O
the 215 218 3240 3243 O
procedure 219 228 3244 3253 O

